Clinical Trial Update: Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating long-term ribavirin in non-responders with chronic hepatitis C and advanced fibrosis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Chronic Hepatitis C | Phase 2 | Status: TERMINATED